| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | methylated histone binding | 2.54e-08 | 86 | 21 | 5 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 2.85e-08 | 88 | 21 | 5 | GO:0140034 | |
| GeneOntologyMolecularFunction | sphingosine N-acyltransferase activity | 3.50e-08 | 7 | 21 | 3 | GO:0050291 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.98e-06 | 206 | 21 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.64e-06 | 119 | 21 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | histone binding | 6.78e-06 | 265 | 21 | 5 | GO:0042393 | |
| GeneOntologyMolecularFunction | symporter activity | 1.66e-05 | 150 | 21 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 8.11e-05 | 81 | 21 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.61e-04 | 102 | 21 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.32e-04 | 296 | 21 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.47e-04 | 301 | 21 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 4.02e-04 | 627 | 21 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 5.23e-04 | 664 | 21 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 7.33e-04 | 171 | 21 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 9.53e-04 | 758 | 21 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.17e-03 | 793 | 21 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.27e-03 | 465 | 21 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.39e-03 | 477 | 21 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.74e-03 | 59 | 21 | 2 | GO:1901505 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.90e-03 | 238 | 21 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 6.57e-03 | 1180 | 21 | 5 | GO:0022857 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 7.95e-03 | 775 | 21 | 4 | GO:0016746 | |
| GeneOntologyMolecularFunction | transporter activity | 9.49e-03 | 1289 | 21 | 5 | GO:0005215 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.38e-02 | 171 | 21 | 2 | GO:0015103 | |
| GeneOntologyBiologicalProcess | ceramide biosynthetic process | 5.40e-05 | 73 | 21 | 3 | GO:0046513 | |
| GeneOntologyBiologicalProcess | ceramide metabolic process | 1.98e-04 | 113 | 21 | 3 | GO:0006672 | |
| GeneOntologyBiologicalProcess | sphingolipid biosynthetic process | 2.20e-04 | 117 | 21 | 3 | GO:0030148 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine biosynthetic process | 4.22e-04 | 30 | 21 | 2 | GO:0006656 | |
| GeneOntologyBiologicalProcess | phosphatidylethanolamine metabolic process | 4.22e-04 | 30 | 21 | 2 | GO:0046337 | |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 5.20e-04 | 157 | 21 | 3 | GO:0046467 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 6.79e-04 | 172 | 21 | 3 | GO:0043604 | |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 7.25e-04 | 176 | 21 | 3 | GO:0006665 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | 1.13e-03 | 813 | 21 | 5 | GO:0008610 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 1.34e-03 | 1293 | 21 | 6 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 1.37e-03 | 1299 | 21 | 6 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 1.53e-03 | 1327 | 21 | 6 | GO:0042175 | |
| Domain | SPIN/Ssty | 5.90e-12 | 5 | 21 | 4 | IPR003671 | |
| Domain | Spin-Ssty | 5.90e-12 | 5 | 21 | 4 | PF02513 | |
| Domain | TLC | 2.13e-09 | 16 | 21 | 4 | PS50922 | |
| Domain | TLC-dom | 2.13e-09 | 16 | 21 | 4 | IPR006634 | |
| Domain | TRAM_LAG1_CLN8 | 2.13e-09 | 16 | 21 | 4 | PF03798 | |
| Domain | TLC | 2.13e-09 | 16 | 21 | 4 | SM00724 | |
| Domain | Lag1/Lac1 | 2.44e-08 | 6 | 21 | 3 | IPR016439 | |
| Domain | SPIN-2 | 1.20e-06 | 2 | 21 | 2 | IPR029564 | |
| Domain | MFS | 8.49e-05 | 77 | 21 | 3 | IPR011701 | |
| Domain | MFS_1 | 8.49e-05 | 77 | 21 | 3 | PF07690 | |
| Domain | MFS | 2.32e-04 | 108 | 21 | 3 | PS50850 | |
| Domain | MFS_dom | 4.37e-04 | 134 | 21 | 3 | IPR020846 | |
| Domain | Homeobox | 2.19e-03 | 234 | 21 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 2.24e-03 | 236 | 21 | 3 | PS00027 | |
| Domain | HOX | 2.27e-03 | 237 | 21 | 3 | SM00389 | |
| Domain | Homeobox_dom | 2.32e-03 | 239 | 21 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 2.32e-03 | 239 | 21 | 3 | PS50071 | |
| Domain | - | 3.74e-03 | 283 | 21 | 3 | 1.10.10.60 | |
| Domain | Homeodomain-like | 5.84e-03 | 332 | 21 | 3 | IPR009057 | |
| Pathway | WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES | 1.19e-06 | 22 | 14 | 3 | M45544 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 2.00e-06 | 26 | 14 | 3 | MM15892 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 2.00e-06 | 26 | 14 | 3 | M39784 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 2.25e-06 | 27 | 14 | 3 | MM14646 | |
| Pathway | WP_SPHINGOLIPID_PATHWAY | 3.12e-06 | 30 | 14 | 3 | M39501 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 5.94e-06 | 37 | 14 | 3 | M554 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 9.29e-05 | 92 | 14 | 3 | MM15086 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 1.46e-04 | 107 | 14 | 3 | M14857 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 2.33e-04 | 620 | 14 | 5 | MM15193 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 2.71e-04 | 25 | 14 | 2 | MM15931 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 2.94e-04 | 26 | 14 | 2 | MM14584 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 3.17e-04 | 27 | 14 | 2 | M39863 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 3.41e-04 | 28 | 14 | 2 | M684 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 5.88e-04 | 757 | 14 | 5 | M27451 | |
| Pubmed | A transcriptional coregulator, SPIN·DOC, attenuates the coactivator activity of Spindlin1. | 1.47e-12 | 6 | 21 | 4 | 29061846 | |
| Pubmed | Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. | 1.90e-10 | 3 | 21 | 3 | 20406683 | |
| Pubmed | Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. | 1.90e-09 | 5 | 21 | 3 | 15823095 | |
| Pubmed | 1.90e-09 | 5 | 21 | 3 | 26887952 | ||
| Pubmed | 3.79e-09 | 6 | 21 | 3 | 17977534 | ||
| Pubmed | 3.79e-09 | 6 | 21 | 3 | 23936132 | ||
| Pubmed | Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis. | 1.06e-08 | 8 | 21 | 3 | 36543979 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17609214 | ||
| Pubmed | Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. | 3.47e-07 | 2 | 21 | 2 | 12145692 | |
| Pubmed | Generation of a ceramide synthase 6 mouse lacking the DDRSDIE C-terminal motif. | 3.47e-07 | 2 | 21 | 2 | 35849604 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19912991 | ||
| Pubmed | 5.50e-07 | 27 | 21 | 3 | 23096701 | ||
| Pubmed | Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. | 5.50e-07 | 27 | 21 | 3 | 25269881 | |
| Pubmed | Regulation of meiotic telomere dynamics through membrane fluidity promoted by AdipoR2-ELOVL2. | 6.86e-07 | 29 | 21 | 3 | 38485951 | |
| Pubmed | Eleven residues determine the acyl chain specificity of ceramide synthases. | 1.04e-06 | 3 | 21 | 2 | 29632068 | |
| Pubmed | CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity. | 1.04e-06 | 3 | 21 | 2 | 31150623 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 34915026 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 12912983 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 23538298 | ||
| Pubmed | SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY. | 2.08e-06 | 4 | 21 | 2 | 26620563 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 12297269 | ||
| Pubmed | PAQR4 regulates adipocyte function and systemic metabolic health by mediating ceramide levels. | 3.47e-06 | 5 | 21 | 2 | 38961186 | |
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 31971349 | ||
| Pubmed | 1.21e-04 | 27 | 21 | 2 | 37995181 | ||
| Pubmed | 1.70e-04 | 32 | 21 | 2 | 24706805 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 2.04e-04 | 942 | 21 | 5 | 31073040 | |
| Pubmed | 2.28e-04 | 37 | 21 | 2 | 29044125 | ||
| Interaction | HTR2C interactions | 9.09e-06 | 130 | 21 | 4 | int:HTR2C | |
| Interaction | P2RY1 interactions | 1.35e-05 | 45 | 21 | 3 | int:P2RY1 | |
| Interaction | SYVN1 interactions | 1.72e-05 | 324 | 21 | 5 | int:SYVN1 | |
| Interaction | P2RY12 interactions | 3.54e-05 | 62 | 21 | 3 | int:P2RY12 | |
| Interaction | VIPR2 interactions | 4.38e-05 | 194 | 21 | 4 | int:VIPR2 | |
| Interaction | LPAR1 interactions | 5.97e-05 | 210 | 21 | 4 | int:LPAR1 | |
| Interaction | DEFB107A interactions | 8.01e-05 | 13 | 21 | 2 | int:DEFB107A | |
| Interaction | PRDM7 interactions | 9.34e-05 | 14 | 21 | 2 | int:PRDM7 | |
| Interaction | C3AR1 interactions | 1.48e-04 | 100 | 21 | 3 | int:C3AR1 | |
| Interaction | CMKLR1 interactions | 1.52e-04 | 101 | 21 | 3 | int:CMKLR1 | |
| Interaction | OPRL1 interactions | 1.57e-04 | 102 | 21 | 3 | int:OPRL1 | |
| Interaction | TSPAN15 interactions | 1.71e-04 | 276 | 21 | 4 | int:TSPAN15 | |
| Interaction | CDY2A interactions | 2.15e-04 | 21 | 21 | 2 | int:CDY2A | |
| Interaction | IPPK interactions | 2.29e-04 | 116 | 21 | 3 | int:IPPK | |
| Interaction | GPR84 interactions | 3.31e-04 | 26 | 21 | 2 | int:GPR84 | |
| Interaction | S1PR4 interactions | 3.74e-04 | 137 | 21 | 3 | int:S1PR4 | |
| Cytoband | Xp11.1 | 1.20e-06 | 4 | 21 | 2 | Xp11.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 6.55e-04 | 377 | 21 | 3 | chrXp11 | |
| GeneFamily | Tudor domain containing|Spindlin family | 1.53e-12 | 5 | 15 | 4 | 1089 | |
| GeneFamily | CERS class homeoboxes | 9.23e-09 | 6 | 15 | 3 | 530 | |
| GeneFamily | Tudor domain containing | 1.99e-08 | 37 | 15 | 4 | 780 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 8.00e-04 | 51 | 15 | 2 | 870 | |
| GeneFamily | Solute carriers | 3.87e-03 | 395 | 15 | 3 | 752 | |
| Coexpression | GSE14308_TH17_VS_INDUCED_TREG_DN | 1.78e-05 | 200 | 21 | 4 | M3386 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-05 | 145 | 21 | 3 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-05 | 166 | 21 | 3 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 21 | 3 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | mild-Lymphocytic-Plasmablast|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.75e-05 | 186 | 21 | 3 | 060510c21b1e0889b7a6eeb15821b9e2f03a0f99 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 190 | 21 | 3 | 992539c380576bf810c00a5f926cf1ee7d57dcf5 | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.07e-04 | 199 | 21 | 3 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Stem_cells-Neuroepithelial_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | c9c832f489629b8724501ddfede984b41a7b674d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Stem_cells|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | d7832ab1ed0ff0a6f7e3ac11b2095dc72c90af44 | |
| ToppCell | mLN-(7)_Mast_cell-(70)_Mast|mLN / shred on region, Cell_type, and subtype | 1.08e-04 | 200 | 21 | 3 | a6c258cae678be581b1d85cf3446c65c34b13499 | |
| ToppCell | mLN-Mast_cell-Mast|mLN / Region, Cell class and subclass | 1.08e-04 | 200 | 21 | 3 | 81ea6e7a3940277751faf9097b30198159998c7b | |
| ToppCell | mLN-Mast_cell|mLN / Region, Cell class and subclass | 1.08e-04 | 200 | 21 | 3 | 9a5f1d99d8d160923d4d0fbbf9ad48a26f8a4fad | |
| ToppCell | mLN-(7)_Mast_cell|mLN / shred on region, Cell_type, and subtype | 1.08e-04 | 200 | 21 | 3 | 13bca944fbdbc0be6687eca82c62a4d231ab94f0 | |
| Drug | scandium phosphate | 8.10e-07 | 2 | 21 | 2 | CID006365269 | |
| Drug | lithium indium | 8.10e-07 | 2 | 21 | 2 | CID011116062 | |
| Drug | rubidium nitrate | 8.10e-07 | 2 | 21 | 2 | CID000025731 | |
| Drug | diphenylketen | 4.86e-06 | 4 | 21 | 2 | CID000013696 | |
| Drug | 5-mm AI | 5.32e-05 | 12 | 21 | 2 | CID000131575 | |
| Drug | AC1NPP2V | 5.71e-05 | 82 | 21 | 3 | CID005207744 | |
| Drug | Verapamil | 9.65e-05 | 16 | 21 | 2 | DB00661 | |
| Disease | X-19141 measurement | 3.75e-05 | 13 | 21 | 2 | EFO_0800799 | |
| Disease | microcephaly (implicated_via_orthology) | 2.36e-04 | 32 | 21 | 2 | DOID:10907 (implicated_via_orthology) | |
| Disease | lymphocyte count | 4.21e-04 | 1464 | 21 | 6 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MTYDEFEYCWDTFVY | 336 | Q9UH17 | |
| IPSQYWYYMIELSFY | 176 | Q96G23 | |
| GLYHYYIMELAFYWS | 186 | Q8N5B7 | |
| WYDMEYDLKYSYFQL | 291 | P0C870 | |
| YQAFMWALYKYFISF | 361 | Q96RT8 | |
| QTYWYLLFYCLFETM | 156 | Q8NA29 | |
| FAYYYFISFYMLCAF | 1356 | Q13698 | |
| HFCEWMYDYSYEKYP | 346 | P35790 | |
| MWRFSFYLYVFTYGV | 136 | Q6ZMG9 | |
| YFCEYWLFYTIMAYT | 301 | Q9Y2C5 | |
| CYYMNWTYVFYFFGT | 221 | Q9NRA2 | |
| WFYITYEKDPVLYMY | 161 | Q99865 | |
| WFYITYEKDPVLYMY | 161 | Q5JUX0 | |
| WFYITYEKDPVLYMY | 151 | Q56A73 | |
| WFYITYEKDPVLYMY | 161 | Q9BPZ2 | |
| YVWFLIPYMIYDSYA | 76 | Q8TBR7 | |
| YFIFTSFWAYKIYYV | 466 | Q9HD45 | |
| YIASYYNTIMAWALY | 171 | P31645 | |
| ISRYWYYLYDNAMCK | 1481 | Q14669 | |
| IYMLYFDFWFQAYDL | 216 | O75795 | |
| FCWFYVYRSEGMKVY | 646 | O76024 |